Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

6.585 -0.155 (-2.30%)
Streaming Delayed Price Updated: 12:22 PM EST, Dec 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about COMPASS Pathways Plc - American Depository Shares

< Previous 1 2
...
24 25 26 27 28 29 30 31 Next >
NetworkNewsAudio – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Differentiates Itself in Psychedelics Space
Via Investor Brand Network
News headline image
Psychedelic Stock Gainers And Losers From March 4, 2022 ↗
GAINERS: Wellbeing Digital (OTC: 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From March 3, 2022 ↗
GAINERS: Seelos Therapeutics (NASDAQ: 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From March 2, 2022 ↗
GAINERS: Mindset Pharma (OTC: 
Via Benzinga
News headline image
Psychedelic Therapies Offer Hope For Mental Health ↗
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.... 
Via Benzinga
Psychedelic Therapies Offer Hope for Mental Health
Via Investor Brand Network
Psychedelic Therapies Offer Hope for Mental Health
Via Investor Brand Network
Psychedelic Therapies Offer Hope for Mental Health
NetworkNewsWire Editorial Coverage New York, NY – March 2, 2022 – Neural plasticity is instrumental in brain health, and the importance of neuroplasticity can’t be overstated. Indeed, the inability of... 
Via FinancialNewsMedia
News headline image
Psychedelic Stock Gainers And Losers From March 1, 2022 ↗
GAINERS: Cybin (AMEX: 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 28, 2022 ↗
GAINERS: Wellbeing Digital (OTC: 
Via Benzinga
News headline image
Psychedelic & Marijuana Drug Stocks Continue To Decline ↗
This article updates the latest stock performances of the 13 clinical-stage companies with the largest market capitalizations which are tracked in the munKNEE Pure-Play Marijuana (4) and the munKNEE... 
Via Talk Markets
News headline image
Field Trip Health, Seelos Therapeutics Among Top Psychedelic Movers Of Today ↗
GAINERS: Field Trip Health (NASDAQ: 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 24, 2022 ↗
GAINERS: Seelos Therapeutics (NASDAQ: 
Via Benzinga
News headline image
COMPASS Pathways Posts Wider Net Loss In Q4, Gives Update On Psilocybin Research ↗
COMPASS Pathways plc (NASDAQ:CMPS) reported its fi... 
Via Benzinga
News headline image
Small Pharma, GH Research Among Top Psychedelic Movers Of Today ↗
GAINERS: Small Pharma (OTC: 
Via Benzinga
News headline image
Compass Pathways Earnings Preview ↗
Compass Pathways (NASDAQ:CMPS) is set to give its latest quarterly earnings report on Thursday, 2022-02-24. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 22, 2022 ↗
GAINERS: LOSERS: Mindset Pharma (OTC: 
Via Benzinga
News headline image
Psychedelic & Marijuana Drug Stocks Continued To Decline Last Week ↗
An update on the stock performances of the 13 clinical-stage psychedelic and marijuana drug companies with the largest market capitalizations.tttttttttt 
Via Talk Markets
News headline image
Field Trip Health, Mind Medicine Among Top Psychedelic Movers Of Today ↗
GAINERS: Field Trip Health (NASDAQ: 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 17, 2022 ↗
GAINERS: Mindset Pharma (OTC: 
Via Benzinga
News headline image
Magic Mushroom's Active Compound Could Relieve Depression For Up To One Year, New Study Finds ↗
A new review study by Johns Hopkins University researchers is shedding light on the long-term effects of psilocybin in the treatment of maj... 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 15, 2022 ↗
GAINERS: Mind Medicine (NASDAQ: 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 14, 2022 ↗
GAINERS: Wellbeing Digital (OTC: 
Via Benzinga
News headline image
Psychedelic And Cannabis Drug Stocks Continue Advance ↗
This article updates the performances of 16 clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses. 
Via Talk Markets
News headline image
Mind Medicine, Cybin Among Top Psychedelic Movers Of Today ↗
GAINERS: Revive Therapeutics (OTC: RVVTF) shares closed up 2.51% at $0.22 LOSERS: Mind Medicine (NASDAQ: MNMD) shares closed down 8.09% at $1.25 Cybin (AMEX:CYBN) shares closed down 6.25% at $1.05 ATAI... 
Via Benzinga
News headline image
Allied, Cybin Among Top Psychedelic Movers Of Today ↗
GAINERS: Allied (OTC:ALID) shares closed up 7.39% at $1.89 
Via Benzinga
News headline image
Psychedelic Stock Gainers And Losers From February 9, 2022 ↗
GAINERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed up 14.29% at $5.76 
Via Benzinga
News headline image
Cathie Wood Is Buying this Peter Thiel-Backed Psychedelics Stock For Ark Funds ↗
There’s a new psychedelics company being added to an ETF from Cathie Wood. What Happened: The Ark Genomic Revolution ETF (BATS: ARKG) took an initial position in shares of... 
Via Benzinga
News headline image
Mindset Pharma, Cybin Among Top Psychedelic Movers Of Today ↗
GAINERS: Awakn Life Sciences (OTC:AWKNF) shares closed up 3.51% at $1.62 
Via Benzinga
News headline image
Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today ↗
GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 9.82% at $1.23 
Via Benzinga
< Previous 1 2
...
24 25 26 27 28 29 30 31 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.